Loading...
XJPX
4894
Market cap223mUSD
Jul 10, Last price  
4,805.00JPY
1D
4.00%
1Q
-31.55%
IPO
198.08%
Name

Cuorips Inc

Chart & Performance

D1W1MN
XJPX:4894 chart
P/E
P/S
177.70
EPS
Div Yield, %
Shrs. gr., 5y
1.67%
Rev. gr., 5y
295.29%
Revenues
212m
+21.19%
220,00013,913,00038,278,00023,102,000175,205,000212,332,000
Net income
-1.02b
L+58.71%
-307,834,000-375,337,000-452,077,000-632,183,000-644,342,000-1,022,641,000
CFO
-1.06b
L+30.43%
-282,797,000-220,762,000-401,612,000-451,060,000-812,616,000-1,059,895,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Cuorips Inc. specializes in the comprehensive lifecycle of iPS cell-derived cardiomyocyte sheets, undertaking their research, development, production, commercialization, and distribution. The firm's portfolio extends to include cellular, tissue-based, and cell processing products. Furthermore, it offers contract development and manufacturing services, alongside expert consulting. The company, which was incorporated in 2017 and is based in Tokyo, Japan, previously operated under the name Cuore Inc. before adopting Cuorips Inc. in June 2017.
IPO date
Jun 27, 2023
Employees
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT